Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal antibodies against pertussis in neonates
2010-023976-16Phase 4Completed
- Sponsor
- University of Antwerp
- Start
- Jan 2011
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acellular pertussis vaccine in pertussis, sponsored by University of Antwerp. Primary endpoints: Maternal pertussis antibody titres at delivery, Neonatal pertussis antibody titres in cord blood and 1 more. Started Jan 2011; status: completed.
02
Drugs
acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on 2010-023976-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023976-16.